145 related articles for article (PubMed ID: 34464028)
1. Novel genetic characteristics in low-grade fetal adenocarcinoma of the lung.
Zhang S; Yin H; Zhang J; Yang L; Yang G; Jia J; Jiao Y; Ying J; Wang Y
Thorac Cancer; 2021 Oct; 12(20):2789-2795. PubMed ID: 34464028
[TBL] [Abstract][Full Text] [Related]
2. Morphologic, Immunohistochemical, and Genetic Differences Between High-grade and Low-grade Fetal Adenocarcinomas of the Lung.
Li Y; Xi SY; Yong JJ; Wu XY; Yang XH; Wang F
Am J Surg Pathol; 2021 Nov; 45(11):1464-1475. PubMed ID: 34138800
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive molecular analysis of genomic profiles and PD-L1 expression in lung adenocarcinoma with a high-grade fetal adenocarcinoma component.
Suzuki M; Kasajima R; Yokose T; Ito H; Shimizu E; Hatakeyama S; Yokoyama K; Yamaguchi R; Furukawa Y; Miyano S; Imoto S; Yoshioka E; Washimi K; Okubo Y; Kawachi K; Sato S; Miyagi Y
Transl Lung Cancer Res; 2021 Mar; 10(3):1292-1304. PubMed ID: 33889510
[TBL] [Abstract][Full Text] [Related]
4. Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules.
Nakatani Y; Masudo K; Miyagi Y; Inayama Y; Kawano N; Tanaka Y; Kato K; Ito T; Kitamura H; Nagashima Y; Yamanaka S; Nakamura N; Sano J; Ogawa N; Ishiwa N; Notohara K; Resl M; Mark EJ
Mod Pathol; 2002 Jun; 15(6):617-24. PubMed ID: 12065775
[TBL] [Abstract][Full Text] [Related]
5. High-grade fetal adenocarcinoma of the lung is a tumour with a fetal phenotype that shows diverse differentiation, including high-grade neuroendocrine carcinoma: a clinicopathological, immunohistochemical and mutational study of 20 cases.
Suzuki M; Yazawa T; Ota S; Morimoto J; Yoshino I; Yamanaka S; Inayama Y; Kawabata Y; Shimizu Y; Komatsu M; Notohara K; Koda K; Nakatani Y
Histopathology; 2015 Dec; 67(6):806-16. PubMed ID: 25851923
[TBL] [Abstract][Full Text] [Related]
6. Differences between low and high grade fetal adenocarcinoma of the lung: a clinicopathological and molecular study.
Zhang J; Sun J; Liang XL; Lu JL; Luo YF; Liang ZY
J Thorac Dis; 2017 Jul; 9(7):2071-2078. PubMed ID: 28840008
[TBL] [Abstract][Full Text] [Related]
7. A case report of low grade fetal lung adenocarcinoma with TP53 mutation.
Wang B; Jin H
Medicine (Baltimore); 2022 Mar; 101(11):. PubMed ID: 35356917
[TBL] [Abstract][Full Text] [Related]
8. Coexistence of Low-Grade Fetal Adenocarcinoma and Adenocarcinoma in situ of the Lung Harboring Different Genetic Mutations: A Case Report and Review of Literature.
Liu S; Wang J; Luo X; Li X; Miao Y; Wang L; Li Q; Qiu X; Wang EH
Onco Targets Ther; 2020; 13():6675-6680. PubMed ID: 32753900
[TBL] [Abstract][Full Text] [Related]
9. Novel gene mutations in well-differentiated fetal adenocarcinoma of the lung in the next generation sequencing era.
Fu Y; Wu Q; Su F; Tang Y; Lin Y; Wang W; Jiang L
Lung Cancer; 2018 Oct; 124():1-5. PubMed ID: 30268445
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic alterations are associated with tumor mutation burden in non-small cell lung cancer.
Cai L; Bai H; Duan J; Wang Z; Gao S; Wang D; Wang S; Jiang J; Han J; Tian Y; Zhang X; Ye H; Li M; Huang B; He J; Wang J
J Immunother Cancer; 2019 Jul; 7(1):198. PubMed ID: 31349879
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive review of fetal adenocarcinoma of the lung.
Ricaurte LM; Arrieta O; Zatarain-Barrón ZL; Cardona AF
Lung Cancer (Auckl); 2018; 9():57-63. PubMed ID: 30197546
[TBL] [Abstract][Full Text] [Related]
12. Morphological and Molecular Characteristics in Low Grade Fetal Adenocarcinoma of the Lung: Two Case Reports and Literature Review.
Yanagawa N; Uesugi N; Nishiya M; Sugimoto R; Osakabe M; Saitoh H; Maemondo M; Sugai T
Int J Surg Pathol; 2022 Oct; 30(7):797-803. PubMed ID: 35188818
[No Abstract] [Full Text] [Related]
13. [High-grade Fetal Adenocarcinoma of the Lung: A Case Report].
Huang C; Ma C; Wu Q; Wang Z; Sun Y; Jiao P; Tian W; Yu H; Tong H
Zhongguo Fei Ai Za Zhi; 2019 Mar; 22(3):183-186. PubMed ID: 30910000
[TBL] [Abstract][Full Text] [Related]
14. Aberrant nuclear/cytoplasmic localization and gene mutation of beta-catenin in classic pulmonary blastoma: beta-catenin immunostaining is useful for distinguishing between classic pulmonary blastoma and a blastomatoid variant of carcinosarcoma.
Nakatani Y; Miyagi Y; Takemura T; Oka T; Yokoi T; Takagi M; Yokoyama S; Kashima K; Hara K; Yamada T; Nozawa A; Inayama Y; Sakamoto K; Ogawa N; Kitamura H; Resl M; Cho SH; Koss MN; Mark EJ
Am J Surg Pathol; 2004 Jul; 28(7):921-7. PubMed ID: 15223963
[TBL] [Abstract][Full Text] [Related]
15. High-grade fetal adenocarcinoma of the lung with abnormal expression of alpha-fetoprotein in a female patient: Case report.
Xiao-Feng L; Guo-Qi Z; Wei H; Jing-Hong L; Chao-Xia D; Xiao-Yan C; Yang X
Medicine (Baltimore); 2021 Feb; 100(7):e24634. PubMed ID: 33607799
[TBL] [Abstract][Full Text] [Related]
16. Genomic scoring to determine clinical benefit of immunotherapy by targeted sequencing.
Kim HS; Cha H; Kim J; Park WY; Choi YL; Sun JM; Ahn JS; Ahn MJ; Park K; Lee SH
Eur J Cancer; 2019 Oct; 120():65-74. PubMed ID: 31493723
[TBL] [Abstract][Full Text] [Related]
17. Morphological, immune and genetic features in biopsy sample associated with the efficacy of pembrolizumab in patients with non-squamous non-small cell lung cancer.
Sakai T; Udagawa H; Matsumoto S; Yoh K; Nosaki K; Ikeda T; Zenke Y; Kirita K; Niho S; Akimoto T; Goto K; Ishii G
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1227-1237. PubMed ID: 32997195
[TBL] [Abstract][Full Text] [Related]
18. Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers.
Hu C; Zhao L; Liu W; Fan S; Liu J; Liu Y; Liu X; Shu L; Liu X; Liu P; Deng C; Qiu Z; Chen C; Jiang Y; Liang Q; Yang L; Shao Y; He Q; Yu D; Zeng Y; Li Y; Pan Y; Zhang S; Shi S; Peng Y; Wu F
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34887263
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary adenocarcinomas of the fetal lung type: a clinicopathologic study indicating differences in histology, epidemiology, and natural history of low-grade and high-grade forms.
Nakatani Y; Kitamura H; Inayama Y; Kamijo S; Nagashima Y; Shimoyama K; Nakamura N; Sano J; Ogawa N; Shibagaki T; Resl M; Mark EJ
Am J Surg Pathol; 1998 Apr; 22(4):399-411. PubMed ID: 9537466
[TBL] [Abstract][Full Text] [Related]
20. Molecular landscape and multi-omic measurements of heterogeneity in fetal adenocarcinoma of the lung.
Sun L; Guo W; Guo L; Chen X; Zhou H; Yan S; Zhao G; Bao H; Wu X; Shao Y; Ying J; Lin L
NPJ Precis Oncol; 2024 Jun; 8(1):99. PubMed ID: 38831114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
